Caplacizumab
Veltuzumab
Abrilumab
Abituzumab
Etrolizumab
Efalizumab
RGD-4C
Etaracizumab
Enlimomab
Volociximab
Ontamalimab
Bersanlimab
Tadocizumab
Rovelizumab
Cyclo(Ala-Arg-Gly-Asp-Mamb)
BT200 sodium
RTDLDSLRTYTL
ATN-161
GSK 3008348 hydrochloride
Fradafiban